
Cardinal Health, Inc. (CAH)
$
225.76
-0.56 (-0.25%)
Key metrics
Financial statements
Free cash flow per share
23.3305
Market cap
53.3 Billion
Price to sales ratio
0.2178
Debt to equity
-3.3433
Current ratio
0.9057
Income quality
3.6414
Average inventory
18.8 Billion
ROE
-0.5893
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Cardinal Health, Inc. operates as an integrated healthcare services and products company providing customized solutions across the United States, Canada, Europe, Asia, and other international markets. The company offers tailored services to hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and home care patients. The company functions in two primary segments: Pharmaceutical and Medical. The Pharmaceutical segment is responsible for distributing both branded and generic pharmaceuticals, specialty pharmaceuticals, and over-the-counter healthcare products. Additionally, it supports pharmaceutical manufacturers and healthcare providers through various services linked to specialty pharmaceuticals; manages nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic and over-the-counter healthcare products; and delivers medication therapy management and patient outcomes services to hospitals, healthcare providers, and payers. The operational income ratio is 0.01 indicating the company's operational profitability margin, while the company recorded an operating income of $2,275,000,000.00 reflecting its earnings from core operations. The income before tax ratio stands at 0.01 which shows the pre-tax margin. On the stock market, the company’s stock is identified with the symbol 'CAH', and the gross profit is $8,168,000,000.00 highlighting the company's profitability from its core operations. Conversely, the Medical segment involves the manufacture, sourcing, and distribution of Cardinal Health branded medical, surgical, and laboratory products, along with a comprehensive range of solutions for healthcare providers. The stock is reasonably priced at $149.60 appealing to a broad array of investors. With a high average trading volume of 2,043,656.00 it demonstrates strong liquidity in the market. The company boasts a mid-range market capitalization of $53,124,947,384.00 positioning it as a steady performer within the industry. As a key player in the Medical - Distribution industry, Cardinal Health significantly contributes to the overall market landscape and embraces its role in driving innovation and growth as part of the Healthcare sector. The combination of a robust product portfolio, strategic market presence, and solid financial metrics underlines the company's commitment to delivering effective healthcare solutions.
Investing in Cardinal Health, Inc. (CAH) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C+, with a Bullish outlook. Always conduct your own research before investing.
Analysts predict Cardinal Health, Inc. stock to fluctuate between $120.72 (low) and $230.81 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-02-09, Cardinal Health, Inc.'s market cap is $53,124,947,384, based on 235,316,032 outstanding shares.
Compared to Eli Lilly & Co., Cardinal Health, Inc. has a Lower Market-Cap, indicating a difference in performance.
Cardinal Health, Inc. pays dividends. The current dividend yield is 0.99%, with a payout of $0.51 per share.
To buy Cardinal Health, Inc. (CAH) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CAH. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Cardinal Health, Inc.'s last stock split was 3:2 on 2001-04-23.
Revenue: $222,578,000,000 | EPS: $6.48 | Growth: 86.21%.
Visit https://www.cardinalhealth.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $230.81 (2026-02-06) | All-time low: $45.85 (2021-12-01).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

seekingalpha.com
Cardinal Health is upgraded to a buy after Q2 2026 delivered robust revenue, margin expansion, and raised full-year guidance. Q2 revenue grew 19% YoY to $65.6B, with non-GAAP EPS up 36% and broad-based segment strength, especially in pharmaceuticals. Management executed $750M in share repurchases YTD, underscoring commitment to capital return and reducing outstanding shares by 2.5%.

zacks.com
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

247wallst.com
Cardinal Health (NYSE: CAH) delivered a decisive second-quarter beat on February 5, 2026, with non-GAAP EPS of $2.63, surpassing the $2.38 consensus estimate by 10.5%.

zacks.com
CAH tops second-quarter fiscal 2026 EPS estimates by 10%, posts strong segment profits, and raises full-year earnings outlook, sending shares higher.

barrons.com
The pharmaceutical distributor and health services company raises its guidance for the second time.

seekingalpha.com
Cardinal Health, Inc. (CAH) Q2 2026 Earnings Call Transcript

zacks.com
Cardinal Health (CAH) came out with quarterly earnings of $2.63 per share, beating the Zacks Consensus Estimate of $2.39 per share. This compares to earnings of $1.93 per share a year ago.

wsj.com
Cardinal Health raised its outlook for the year after logging higher profit and revenue in its fiscal second quarter.

prnewswire.com
Revenue increased 19% to $65.6 billion GAAP 1 operating earnings increased 29% to $707 million; GAAP diluted EPS increased 19% to $1.97 Non-GAAP operating earnings increased 38% to $877 million; non-GAAP diluted EPS increased 36% to $2.63 Cardinal Health raises fiscal year 2026 non-GAAP EPS guidance2 to $10.15 to $10.35 Cardinal Health completes annual baseline share repurchase of $750 million Cardinal Health reaches targeted leverage range 3 DUBLIN, Ohio, Feb. 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the second quarter of fiscal year 2025. Second quarter GAAP operating earnings increased 29% to $707 million and GAAP diluted earnings per share (EPS) increased 19% to $1.97.

zacks.com
Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.
See all news